Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
Jan 29, 2024 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
UPDATED: FDA lists all doses of Novo's Wegovy as available, …
Oct 31, 2024 · Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, a similar situation is playing out for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 · The company acknowledged that some patients may struggle to fill their prescriptions due to “the unprecedented demand for these medicines,” a Lilly spokesperson recently told Fierce Pharma ...
Trump won a second term. What does it mean for biopharma?
Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
Iterum nabs FDA approval for oral UTI drug after prior rejection
Oct 25, 2024 · Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem.
In long-awaited deal, Sun finally buys out Taro for $348M - Fierce …
Jan 18, 2024 · In its most recent financial report, Taro posted revenue of $593 million for the 12 months ending on Sept. 30, 2023, for a 4% increase year over year. Taro’s annual revenue has generally been in ...
Leo Pharma to chop or relocate 250 roles under ongoing revamp
Oct 9, 2024 · Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round of layoffs and relocations. | Leo is closing and relocating up to 250 ...